Delivery Order SPE2DB20D2001-SPE2DB24FM46F
- Not listed
- This federal contract award is for the delivery of Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,347.15 and an ultimate completion date of November 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of 4,563,202,779 units of Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA). The contract, a Delivery Order valued at $2,858.04, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through January 2, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen....
- This federal contract award is for the delivery of 4,563,310,435 units of Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA), which is a defense agency. The contract was awarded on January 11, 2024, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $1,541.82. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 12, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,530.74, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of October 17, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,819.80, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. This is a firm fixed-price delivery order contract that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,102,829 units of Tamsulosin HCl 0.4 mg capsules. The contract, a Firm Fixed Price Delivery Order, has a completion date of October 16, 2024 and a ceiling value of $16,332.76. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which serves as the...
- This federal contract award is for the delivery of Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract, valued at $9,373.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of January 23, 2023. The contract is not designated as a set-aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 1,000 capsules of Tamsulosin HCl 0.4 mg. The contract has a firm fixed price of $1,798.61 and a completion date of December 6, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The $4,297.74 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of December 12, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a ceiling value of $1,504.35 for the procurement of 1,000 capsules of Tamsulosin HCl 0.4 mg. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 11, 2024, with a performance period through July 12, 2024. The contract is a firm fixed-price agreement and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM46FDelivery Order
This federal contract award is for the delivery of 1,000 units of Tamsulosin HCl 0.4 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 21, 2024 with a completion date of February 22, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,805.29. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a for-profit organization. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as a primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 2/21/24 |